HIPPA. If the individual, obtaining consent, works under the HIPAA Covered Entity this is covered under Health Care Operations If the individual obtaining consent does not work under the HIPAA covered entity, HIPAA does not apply.
HIPPA. Buyer is a “hybrid covered entity” as such term is defined in the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), and is in full compliance with all of its obligations under HIPAA and the regulations issued thereunder (the “HIPAA Regulations”).
HIPPA. Health Insurance Portability and Accountability Act (HIPPA) of 1996 that protects certain health information. The Privacy Rule was issued to protect the privacy of health information that identifies individuals who are living or deceased. HUMAN SUBJECTS: Individuals whose physiologic or behavioral characteristics and responses are the object of study in a research project. Under the federal regulations, human subjects are defined as: living individual(s) about whom an investigator conducting research obtains: (1) data through intervention or interaction with the individual; or (2) identifiable private information.
HIPPA. In addition to Customer's other obligations set forth herein, Customer specifically acknowledges and agrees that: (a) Modjoul is not acting on Customer’s behalf as a Business Associate or subcontractor (as such terms are used, defined, or described in the Health Insurance Portability and Accountability Act of 1996, as amended and supplemented (“HIPAA”); (b) the Subscription Services are not HIPAA-compliant; and (c) Customer may not use the Subscription Services in any manner that would require Modjoul or the Subscription Services to be HIPAA- compliant.
HIPPA. The Health Insurance Portability and Accountability Act (HIPAA) is a federal law that provides privacy protections and patient rights about the use and disclosure of your Protected Health Information (PHI). Under HIPPA, I am only allowed to release your PHI for three purposes:
HIPPA. The parties agree that:
HIPPA. Buyer agrees to comply in all respects with the requirements of HIPPA and to cause Company employees to cooperate with Seller with respect to any protected health information that Company employees possess with respect to any Seller Benefit Plan, to the extent required by HIPPA or by the terms of the HIPPA privacy amendment contained in the Seller’s self-insured group health plan.
HIPPA. We understand that medical information about you and your condition is personal. We are committed to protecting medical information about you. Please review Rolling Hills Rehab Center’s Notice of Long-Term Care Facilities Privacy Practice.
HIPPA. School voluntarily provides students with training on the requirements of the Health Insurance Portability and Accountability Act (HIPAA). Training Site will provide additional training on Training Site’s specific HIPAA policies and procedures. School will direct its students and faculty to comply with the policies and procedures of Training Site. No protected healthcare information (PHI) is anticipated to be exchanged between Training Site and School. Solely for the purpose of defining students’ role in relation to the use and disclosure of Training Site’s PHI, students acting pursuant to this Agreement are defined as members of Training Site’s workforce. However, School’s students and faculty shall not be considered to be employees of Training Site. SKAGIT VALLEY COLLEGE *TRAINING SITE NAME* Printed Name Printed Name Signature Date Signature Date Title Title Approved as to form: Approval on file Assistant Attorney General Attorney for College ATTACHMENT A: LETTER AGREEMENT FOR PRECEPTORSHIP
HIPPA. An outpatient consenting and screening visit is scheduled for volunteers who express interest in the study Copies of the approved consent and assent forms are sent to potential subjects beforehand, and we request that the volunteer and her parents review and discuss the forms prior to the screening visit. The consent and screening visit is held in an outpatient examination room in the CRU or alternate UVA clinical unit. This allows a private conversation between the screening physician and/or study coordinator, the potential participant, and at least one of her parents (other individuals such as family members are allowed in the room if desired by the potential participant). The screening visit usually occurs in the morning, although rarely it will occur in the afternoon. The aims, procedures, and potential risks of the study are first explained by the study physician. Importantly, the potential participant and her parents are given an opportunity to ask any questions, and concerns are addressed. In cases where the potential participant wants to begin the study and her parents concur, the participant, parents, and physician and/or study coordinator sign the consent form. In cases where only one parent is able to come to the screening visit, we allow the second parent to sign the form in advance of the visit. This is done in conjunction with a conversation during which we offer that parent an opportunity to ask any questions and confirm that they understand the study and are willing for their daughter to participate. We routinely inform potential participants verbally that signing the consent form does not compel them to continue participation in the study. The remainder of the outpatient screening visit (i.e., history, physical, screening blood tests) occurs immediately thereafter. Participants generally begin the main part of the study within 1-2 months of the screening visit.
